DENTSPLY Sirona Inc (XRAY) Stock: Analyzing the Market Value

The 36-month beta value for XRAY is at 0.98. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 5 rating it as “overweight,” 7 as “hold,” and 1 as “sell.”

The public float for XRAY is 197.58M, and currently, shorts hold a 6.97% of that float. The average trading volume for XRAY on November 27, 2024 was 3.10M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

XRAY) stock’s latest price update

The stock price of DENTSPLY Sirona Inc (NASDAQ: XRAY) has dropped by -1.69 compared to previous close of 19.52. Despite this, the company has seen a gain of 1.64% in its stock price over the last five trading days. globenewswire.com reported 2024-11-26 that BOCA RATON, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) — Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Southern District of New York against Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and U.S. Securities and Exchange Commission (“SEC”) Rule 10b-5 promulgated thereunder on behalf of all persons and entities that purchased Dentsply common stock between December 1, 2022 and November 6, 2024, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Saxena White is captioned North Collier Fire Control and Rescue District Firefighters’ Retirement Plan v. Dentsply Sirona Inc., et al., No. 24-cv-9083 (S.D.N.Y.).

XRAY’s Market Performance

DENTSPLY Sirona Inc (XRAY) has experienced a 1.64% rise in stock performance for the past week, with a -18.72% drop in the past month, and a -22.40% drop in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 3.74% for XRAY. The simple moving average for the last 20 days is -3.28% for XRAY’s stock, with a simple moving average of -29.14% for the last 200 days.

Analysts’ Opinion of XRAY

Needham, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $29, previously predicting the price at $34. The rating they have provided for XRAY stocks is “Buy” according to the report published on October 25th, 2024.

Needham gave a rating of “Buy” to XRAY, setting the target price at $34 in the report published on August 20th of the current year.

XRAY Trading at -16.46% from the 50-Day Moving Average

After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.96% of loss for the given period.

Volatility was left at 3.74%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares sank -17.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.10% lower at present.

During the last 5 trading sessions, XRAY rose by +1.64%, which changed the moving average for the period of 200-days by -42.75% in comparison to the 20-day moving average, which settled at $19.84. In addition, DENTSPLY Sirona Inc saw -46.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 5,000 shares at the price of $18.37 back on Nov 18 ’24. After this action, LUCIER GREGORY T now owns 71,730 shares of DENTSPLY Sirona Inc, valued at $91,850 using the latest closing price.

LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 1,000 shares at $18.28 during a trade that took place back on Nov 15 ’24, which means that LUCIER GREGORY T is holding 16,000 shares at $18,279 based on the most recent closing price.

Stock Fundamentals for XRAY

Current profitability levels for the company are sitting at:

  • -0.07 for the present operating margin
  • 0.52 for the gross margin

The net margin for DENTSPLY Sirona Inc stands at -0.11. The total capital return value is set at -0.05. Equity return is now at value -14.08, with -5.97 for asset returns.

Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 0.89. The interest coverage ratio of the stock is -3.61.

Currently, EBITDA for the company is 232.0 million with net debt to EBITDA at 25.95. When we switch over and look at the enterprise to sales, we see a ratio of 1.5. The receivables turnover for the company is 5.81for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.

Conclusion

In conclusion, DENTSPLY Sirona Inc (XRAY) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts